Key Details

  • Meeting of Board of Directors scheduled for Monday, November 2, 2026
  • Primary agenda: Consider and approve Unaudited Standalone and Consolidated Financial Results for quarter and half year ended September 30, 2026
  • Secondary agenda: Any other business with permission of the Chair

Trading Window Closure

  • Trading Window closed for all Directors, Designated Persons, Connected Persons and their Relatives
  • Closure period: From Thursday, October 1, 2026 until 48 hours after declaration of Unaudited Financial Results for Q2 FY27
  • Explicit advisory against trading in company securities during closure period